Browsing Brage INN by Author "Wolf, Asia-Sophia Fumika Michaela"
Now showing items 1-2 of 2
-
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
Ørbo, Hilde Sofie Sager; Kasahara, Taissa de Matos; Wolf, Asia-Sophia Fumika Michaela; Bjørlykke, Kristin H.; Sexton, Joseph; Jyssum, Ingrid; Tveter, Anne Therese; Solum, Guri; Kjønstad, Ingrid Fadum; Bhandari, Sabin; Christensen, Ingrid Egeland; Kvien, Tore Kristian Aaserud; Lind, Andreas; Kared, Hassen; Jahnsen, Jørgen; Haavardsholm, Espen A.; Munthe, Ludvig Andre; Provan, Sella Aarrestad; Vaage, John T.; Mjaaland, Siri; Syversen, Silje Watterdal; Jørgensen, Kristin Kaasen; Grødeland, Gunnveig; Goll, Guro Løvik (Peer reviewed; Journal article, 2024)Background As most people now have established hybrid immunity, the need for regular, updated SARS-CoV-2 vaccine boosters in patients with immune-mediated inflammatory diseases (IMIDs) is unclear. The study aim was to ... -
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study
Wolf, Asia-Sophia Fumika Michaela; Hammersbøen, Kristin Reine; Ørbo, Hilde Sofie Sager; Bhandari, Sabin; Solum, Guri; Kjønstad, Ingrid Fadum; Jyssum, Ingrid; Nygaard, Unni Cecilie; Kristoffersen, Anja Bråthen; Christensen, Ingrid Egeland; Josefsson, Sarah Elisabet; Lund, Katrine Persgård; Chopra, Adity; Osen, Julie Røkke; Chaban, Viktoriia; Tveter, Anne Therese; Sexton, Joseph; Kvien, Tore Kristian Aaserud; Jahnsen, Jørgen; Haavardsholm, Espen A.; Grødeland, Gunnveig; Vaage, John T.; Provan, Sella Aarrestad; Kared, Hassen; Lund-Johansen, Fridtjof; Munthe, Ludvig Andre; Syversen, Silje Watterdal; Goll, Guro Løvik; Jørgensen, Kristin Kaasen; Mjaaland, Siri (Peer reviewed; Journal article, 2024)Background Understanding cellular responses to SARS-CoV-2 immunisations is important for informing vaccine recommendations in patients with inflammatory bowel disease (IBD) and other vulnerable patients on immunosuppressive ...